Mary Kay Fenton
2018 - Achillion Pharmaceuticals
In 2018, Mary Kay Fenton earned a total compensation of $1.1M as Former Executive Vice President, Chief Financial Officer and Treasurer at Achillion Pharmaceuticals, a 9% increase compared to previous year.
Compensation breakdown
| Option Awards | $505,000 |
|---|---|
| Salary | $382,130 |
| Other | $195,762 |
| Total | $1,082,892 |
Fenton received $505K in option awards, accounting for 47% of the total pay in 2018.
Fenton also received $382.1K in salary and $195.8K in other compensation.
Rankings
In 2018, Mary Kay Fenton's compensation ranked 8,834th out of 14,244 executives tracked by ExecPay. In other words, Fenton earned more than 38.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,834 out of 14,244 | 38th |
Division Manufacturing | 3,518 out of 5,765 | 39th |
Major group Chemicals And Allied Products | 1,331 out of 2,128 | 38th |
Industry group Drugs | 1,115 out of 1,817 | 39th |
Industry Pharmaceutical Preparations | 868 out of 1,391 | 38th |
Source: SEC filing on April 15, 2019.
Fenton's colleagues
We found five more compensation records of executives who worked with Mary Kay Fenton at Achillion Pharmaceuticals in 2018.
2018
Joseph Truitt
Achillion Pharmaceuticals
Chief Executive Officer
2018
Milind Deshpande
Achillion Pharmaceuticals
Chief Executive Officer
2018
Steven Zelenkofske
Achillion Pharmaceuticals
Chief Medical Officer
2018
Paul Firuta
Achillion Pharmaceuticals
Chief Operating Officer
2018
Anthony Gibney
Achillion Pharmaceuticals